Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB00532_nanopub.RA0UMv50Cu1eFual0LmVnCOBfph42SmzUpTb2K4Zaa9A0#assertion>. }
Showing items 1 to 21 of
21
with 100 items per page.
- drugbank:DB00532 type drugbank_vocabulary:Drug assertion.
- drugbank:DB00532 label "Mephenytoin [drugbank:DB00532]" assertion.
- drugbank:DB00532 seeAlso DB00532 assertion.
- drugbank:DB00532 seeAlso mephenytoin.html assertion.
- drugbank:DB00532 identifier "drugbank:DB00532" assertion.
- drugbank:DB00532 description "Mephenytoin is a hydantoin-derivative anticonvulsant used to control various partial seizures. It is generally reserved for treatment of individuals refractory to less toxic agents. Mephenytoin and oxazolidinedione derivatives are associated with higher incidences of blood dyscrasias compared to other anticonvulsants. As such, these agents should not be used concurrently." assertion.
- drugbank:DB00532 title "Mephenytoin" assertion.
- drugbank:DB00532 bio2rdf_vocabulary:identifier "DB00532" assertion.
- drugbank:DB00532 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB00532 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB00532" assertion.
- drugbank:DB00532 bio2rdf_vocabulary:x-identifiers.org DB00532 assertion.
- drugbank:DB00532 drugbank_vocabulary:drugbank-id "APRD00512" assertion.
- drugbank:DB00532 drugbank_vocabulary:drugbank-id "DB00532" assertion.
- drugbank:DB00532 drugbank_vocabulary:x-cas cas:50-12-4 assertion.
- drugbank:DB00532 drugbank_vocabulary:x-chemspider chemspider:3920 assertion.
- drugbank:DB00532 drugbank_vocabulary:x-pubchemcompound pubchem.compound:4060 assertion.
- drugbank:DB00532 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:46508677 assertion.
- drugbank:DB00532 drugbank_vocabulary:x-kegg kegg:D00375 assertion.
- drugbank:DB00532 drugbank_vocabulary:x-pharmgkb pharmgkb:PA450373 assertion.
- drugbank:DB00532 drugbank_vocabulary:x-wikipedia wikipedia:Mephenytoin assertion.
- drugbank:DB00532 drugbank_vocabulary:x-ndc ndc:0078-0052-05 assertion.